Literature DB >> 29619624

Chinese guidelines for treatment of adult primary immune thrombocytopenia.

Xin-Guang Liu1, Xiao-Chuan Bai2, Fang-Ping Chen3, Yun-Feng Cheng4, Ke-Sheng Dai5, Mei-Yun Fang6, Jian-Ming Feng7, Yu-Ping Gong8, Tao Guo9, Xin-Hong Guo10, Yue Han5, Luo-Jia Hong11, Yu Hu9, Bao-Lai Hua12, Rui-Bing Huang13, Yan Li14, Jun Peng1, Mi-Mi Shu15, Jing Sun16, Pei-Yan Sun17, Yu-Qian Sun18, Chun-Sen Wang19, Shu-Jie Wang20, Xiao-Min Wang21, Cong-Ming Wu22, Wen-Man Wu23, Zhen-Yu Yan24, Feng-E Yang25, Lin-Hua Yang26, Ren-Chi Yang27, Tong-Hua Yang28, Xu Ye29, Guang-Sen Zhang30, Lei Zhang27, Chang-Cheng Zheng31, Hu Zhou32, Min Zhou33, Rong-Fu Zhou34, Ze-Ping Zhou35, Hong-Li Zhu36, Tie-Nan Zhu20, Ming Hou37.   

Abstract

Primary immune thrombocytopenia (ITP) is a bleeding disorder commonly encountered in clinical practice. The International Working Group (IWG) on ITP has published several landmark papers on terminology, definitions, outcome criteria, bleeding assessment, diagnosis, and management of ITP. The Chinese consensus reports for diagnosis and management of adult ITP have been updated to the 4th edition. Based on current consensus positions and new emerging clinical evidence, the thrombosis and hemostasis group of the Chinese Society of Hematology issued Chinese guidelines for management of adult ITP, which aim to provide evidence-based recommendations for clinical decision making.

Entities:  

Keywords:  Diagnosis, management; Guideline; Primary immune thrombocytopenia

Mesh：

Year:  2018        PMID： 29619624     DOI： 10.1007/s12185-018-2445-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  56 in total

1.  A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia.

Authors:  Donald M Arnold; Nancy M Heddle; Julie Carruthers; Deborah J Cook; Mark A Crowther; Ralph M Meyer; Yang Liu; Richard J Cook; Anne McLeod; Janet A MacEachern; Joy Mangel; David Anderson; Linda Vickars; Alan Tinmouth; Andre C Schuh; John G Kelton
Journal:  Blood       Date:  2012-01-05       Impact factor: 22.113

2.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

3.  Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases.

Authors:  I Quiquandon; P Fenaux; M T Caulier; D Pagniez; J J Huart; F Bauters
Journal:  Br J Haematol       Date:  1990-02       Impact factor: 6.998

4.  High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.

Authors:  Yu Wei; Xue-bin Ji; Ya-wen Wang; Jing-xia Wang; En-qin Yang; Zheng-cheng Wang; Yu-qi Sang; Zuo-mu Bi; Cui-ai Ren; Fang Zhou; Guo-qiang Liu; Jun Peng; Ming Hou
Journal:  Blood       Date:  2015-10-19       Impact factor: 22.113

5.  Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study.

Authors:  Rami Kotb; Caroline Pinganaud; Catherine Trichet; Olivier Lambotte; Marie Dreyfus; Jean-François Delfraissy; Gil Tchernia; Cécile Goujard
Journal:  Eur J Haematol       Date:  2005-07       Impact factor: 2.997

6.  Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.

Authors:  Douglas B Cines; Terry Gernsheimer; Jeffrey Wasser; Bertrand Godeau; Drew Provan; Roger Lyons; Ivy Altomare; Xuena Wang; Angela Lopez
Journal:  Int J Hematol       Date:  2015-07-23       Impact factor: 2.490

Review 7.  The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.

Authors:  Deirdra R Terrell; Laura A Beebe; Sara K Vesely; Barbara R Neas; Jodi B Segal; James N George
Journal:  Am J Hematol       Date:  2010-03       Impact factor: 10.047

8.  Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis.

Authors:  J Pizzuto; R Ambriz
Journal:  Blood       Date:  1984-12       Impact factor: 22.113

9.  Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group.

Authors:  D Ben-Yehuda; S Gillis; A Eldor
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

Review 10.  Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature.

Authors:  A Salama; M Rieke; H Kiesewetter; M von Depka
Journal:  Ann Hematol       Date:  2008-09-12       Impact factor: 3.673
View more
  19 in total

1.  Effect of postdose fasting duration on hetrombopag olamine pharmacokinetics and pharmacodynamics in healthy volunteers.

Authors:  Guoping Yang; Ranglang Huang; Shuang Yang; Xingfei Zhang; Xiaoyan Yang; Honghui Chen; Zhijun Huang; Chengxian Guo; Qi Pei; Yanfei Tai; Yancong Shen; Jie Huang; Chan Zou
Journal:  Br J Clin Pharmacol       Date:  2020-03-08       Impact factor: 4.335

2.  Health-Related Quality of Life and Burden of Fatigue in Chinese Patients with Immune Thrombocytopenia: A Cross-Sectional Study.

Authors:  Ran Yang; Hao Yao; Lin Lin; Jian-Min Ji; Qun Shen
Journal:  Indian J Hematol Blood Transfus       Date:  2019-06-15       Impact factor: 0.900

3.  Enhancing autophagy protects platelets in immune thrombocytopenia patients.

Authors:  Chun-Yan Wang; Sai Ma; Shao-Jie Bi; Le Su; Shu-Ya Huang; Jun-Ying Miao; Chun-Hong Ma; Cheng-Jiang Gao; Ming Hou; Jun Peng
Journal:  Ann Transl Med       Date:  2019-04

4.  Risk factors and predictors of treatment responses and complications in immune thrombocytopenia.

Authors:  Shin Yeu Ong; Chuen Wen Tan; Vajjhala Ramya; Aisyah A Malik; Xiu Hue Lee; Jordan C C Hwang; Yong Yang; Heng Joo Ng; Lai Heng Lee
Journal:  Ann Hematol       Date:  2021-01-30       Impact factor: 3.673

5.  Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice.

Authors:  Xiaoling Cheng; LingLing Fu; Jingyao Ma; Hao Gu; Zhenping Chen; Libo Zhao; Xiaoling Wang; Runhui Wu
Journal:  Blood Adv       Date:  2021-10-12

6.  Thrombopoietin enhances hematopoietic stem and progenitor cell homing by impeding matrix metalloproteinase 9 expression.

Authors:  Yiming Liu; Li Ding; Bowen Zhang; Ziliang Deng; Yi Han; Sihan Wang; Shu Yang; Zeng Fan; Jing Zhang; Hongmin Yan; Dongmei Han; Lijuan He; Wen Yue; Hengxiang Wang; Yanhua Li; Xuetao Pei
Journal:  Stem Cells Transl Med       Date:  2020-03-03       Impact factor: 6.940

7.  Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia.

Authors:  Dawei Cui; Yan Lv; Xinwang Yuan; Guoxiang Ruan; Yu Zhang; Cuilin Yan; Dandan Xu; Mengen Lv; Yun Mao; Jianping Cao; Jie Jin; Jue Xie
Journal:  J Immunol Res       Date:  2019-03-03       Impact factor: 4.818

8.  Leukemia relapse after transplantation - a consensus on monitoring, prevention, and treatment in China.

Authors:  Huichun Zhan
Journal:  BMC Med       Date:  2019-02-12       Impact factor: 8.775

9.  A Rare Big Chinese Family With Thrombocytopenia 2: A Case Report and Literature Review.

Authors:  Chengning Tan; Limeng Dai; Zhengqiong Chen; Wuchen Yang; Yali Wang; Cheng Zeng; Zheng Xiang; Xiaojie Wang; Xiaomei Zhang; Qian Ran; Hong Guo; Zhongjun Li; Li Chen
Journal:  Front Genet       Date:  2020-04-15       Impact factor: 4.599

10.  Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study.

Authors:  Yimei Feng; Yunshuo Xiao; Hongju Yan; Ping Wang; Wen Zhu; Kaniel Cassady; Zhongmin Zou; Kaifa Wang; Ting Chen; Yao Quan; Zheng Wang; Shijie Yang; Rui Wang; Xiaoping Li; Lei Gao; Cheng Zhang; Yao Liu; Peiyan Kong; Li Gao; Xi Zhang
Journal:  Front Med (Lausanne)       Date:  2020-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.